BIS

ProShares UltraShort Nasdaq Biotech
NASDAQ

Real-time Quotes | Provided by Morningstar

7.61
+0.04
+0.53%
Closed 16:00 07/09 EDT
OPEN
7.49
PREV CLOSE
7.57
HIGH
7.84
LOW
7.47
VOLUME
259.77K
TURNOVER
--
52 WEEK HIGH
21.45
52 WEEK LOW
7.42
TOTAL ASSET
12.03M
YTD YIELD
-43.42%
1D
5D
1M
3M
1Y
5Y

BIS News

More
UGAZ, UCO, LABU and SCO among weekly ETF movers
Seeking Alpha - Article · 06/19 21:35
ACADIA Pharmaceuticals: The Worst-Case Scenario For Investors
Seeking Alpha - Article · 06/08 00:01
Dems attack Trump over stalled efforts to lower drug prices
Seeking Alpha - Article · 02/21 14:32
Drugmakers getting creative over ways to pay for pricey meds
Seeking Alpha - Article · 01/13 17:16
California mulling private-label generics to address high drug costs
Seeking Alpha - Article · 01/09 15:05
End-of-year drug approvals in U.S. associated with more adverse events - study
Seeking Alpha - Article · 01/03 13:07
Drugmakers to hike U.S. prices of over 200 meds
Seeking Alpha - Article · 12/31/2019 21:33
House passes drug pricing bill, Senate unlikely to support
Seeking Alpha - Article · 12/12/2019 21:30

Profile

Fund Name
ProShares UltraShort Nasdaq Biotech
Inception Date
2010-04-06
Benchmark
NASDAQ Biotechnology TR USD*(-200.0%)
Advisor Company
ProShares
Custodian
JPMorgan
Manager
Michael Neches, Devin Sullivan, Tarak Davé

Asset Allocation

12.79M
  • -192.9687%
  • 0.00%
  • 292.9687%
  • 0.00%

2020 Q2

12.79M

2020 Q1

21.12M

2019 Q4

26.19M

2019 Q2

38.00M

2019 Q1

34.09M

Dividend History

Ex-Div Date
Dividend Per Share
03/25/2020
0.0264
12/24/2019
0.0413
09/25/2019
0.0812
06/25/2019
0.0963
03/20/2019
0.0636
More